sulfadiazine has been researched along with Cerebral Ischemia in 1 studies
Sulfadiazine: One of the short-acting SULFONAMIDES used in combination with PYRIMETHAMINE to treat toxoplasmosis in patients with acquired immunodeficiency syndrome and in newborns with congenital infections.
sulfadiazine : A sulfonamide consisting of pyrimidine with a 4-aminobenzenesulfonamido group at the 2-position.
diazine : The parent structure of the diazines.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Villarreal, A | 1 |
| Aviles Reyes, RX | 1 |
| Angelo, MF | 1 |
| Reines, AG | 1 |
| Ramos, AJ | 1 |
1 other study available for sulfadiazine and Cerebral Ischemia
| Article | Year |
|---|---|
S100B alters neuronal survival and dendrite extension via RAGE-mediated NF-κB signaling.
Topics: Animals; Antibodies; Brain Ischemia; Cell Survival; Cells, Cultured; Cerebral Cortex; Dendrites; Dru | 2011 |